Animal models of inflammatory bowel disease

Journal of Pharmacological and Toxicological Methods

Volumn 50, Issue 2, 2004, Pages 81-92

  Jurjus, Abdo R ^a   Khoury, Naim N ^a   Reimund, Jean Marie ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b INSERM   (France)

Author keywords

Animal models; Crohn's disease; Inflammatory bowel disease; Methods; Therapeutic use of models; Ulcerative colitis

Indexed keywords

2 PYRIDYLCARBAMIC ACID 2 [[5 (2 METHOXYPHENOXY) 6 [[(4 ISOPROPYLPHENYL) SULFONYL]AMINO] 2 MORPHOLINO 4 PYRIMIDINYL]OXY]ETHYL ESTER; 2 PYRIDYLCARBAMIC ACID 2 [[5 (2 METHOXYPHENOXY) 6 [[(4 ISOPROPYLPHENYL)SULFONYL]AMINO] 2 MORPHOLINO 4 PYRIMIDINYL]OXY]ETHYL ESTER; 3 AMINOBENZAMIDE; ACETIC ACID; ACETYLCYSTEINE; ADENOVIRUS VECTOR; ANTIANGINA PECTORIS AGENT; ANTIOXIDANT; BOSENTAN; CIPROFLOXACIN; CLODRONIC ACID; CORTICOSTEROID; FOLIC ACID; GREEN TEA EXTRACT; HEPARIN; IMIPENEM; INDOMETACIN; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 4 ANTIBODY; IODOACETAMIDE; MESALAZINE; METRONIDAZOLE; MICROSPHERE; PHENOL DERIVATIVE; SALAZOSULFAPYRIDINE; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ANIMAL MODEL; CANCER PREVENTION; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG EFFICACY; ENTERITIS; HUMAN; KNOCKOUT GENE; KNOCKOUT MOUSE; NONHUMAN; REVIEW; SIDE EFFECT; TRANSGENIC MOUSE; ULCERATIVE COLITIS; VITAMIN SUPPLEMENTATION;

ANIMALIA;

EID: 4644294467     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2003.12.002     Document Type: Article

References (72)

1. Ahn, B. O., Ko, K. H., Oh, T. Y., Cho, H., Kim, W. B., Lee, K. J., Cho, S. W., & Hahm, K.B. (2001). Efficacy of use of colonoscopy in dextran sulfate induced ulcerative colitis in rats: The evaluation of the effects of antioxidant by colonoscopy. International Journal of Colorectal Diseases, 16, 174-181. Antibody to colonic surfactant-like particle. Inflammatory bowel diseases, 5, 16-23.
2. Ahn, B. O., Ko, K. H., Oh, T. Y., Cho, H., Kim, W. B., Lee, K. J., Cho, S. W., & Hahm, K.B. (2001). Efficacy of use of colonoscopy in dextran sulfate induced ulcerative colitis in rats: The evaluation of the effects of antioxidant by colonoscopy. International Journal of Colorectal Diseases, 16, 174-181. Antibody to colonic surfactant-like particle. Inflammatory bowel diseases, 5, 16-23.
3. Araki Y., Tsujikawa T., Andoh A., Sasaki M., Fujiyama Y., Bamba T. Therapeutic effects of an oral adsorbent on acute dextran sulphate sodium-induced colitis and its recovery phase in rats, especially effects of elimination of bile acids in gut lumen. Digestive and Liver Disease. 32:2000;691-698
4. Ballinger A., El-Haj T., Perrett D., Turvill J., Obeid O., Dryden S., Williams G., Farthing M.J.G. Increased activity of hypothalamic serotonergic neurones contributes to suppression of feeding in a rat model of colitis. Gastroenterology. 118:2000;544-553
5. Bamias G., Marini M., Moskaluk C.A., Odashima M., Ross W.G., Riviera-Nieves J., Cominelli F. Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease. Journal of Immunology. 169:2002;5308-5314
6. Bhan A., Mizoguchi E., Smith R., Mizoguchi A. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunological Reviews. 169:1999;195-207
7. Boirivant M., Fuss I., Chu A., Strober W. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. Journal of Experimental Medicine. 188:1998;1929-1939
8. Boise L.H., Minn A.J., Noel P.J., June C.H., Accavitti M.A., Lindsten T., Thompson C.B. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity. 3:1995;87-98
9. Boone D.L., Dassopouols T., Lodolce J.P., Chai S., Chien M., Ma A. Interleukin-2-deficient mice develop colitis in the absence of CD28 costimulation. Inflammatory Bowel Diseases. 8:2002;35-42
10. + T-cells from SCID mice with colitis undergo Fas-mediated apoptosis in vivo. Immunology Letters. 78:2001;7-12
11. Camoglio L., Juffermans N.P., Peppelenbosch M., te Velde A.A., ten Kate F.J., van Deventer S.J.H., Kopf M. Contrasting roles of IL-12p40 and IL-12p35 in the development of hapten-induced colitis. European Journal of Immunology. 32:2002;261-269
12. Cantorna M.T., Munsick C., Bemiss C., Mahon B.D. 1, 25- Dihydroxycholecalciferol prevents and ameliorated symptoms of experimental murine inflammatory bowel disease. Journal of Nutrition. 130:2000;2648-2652
13. Choudhary S., Keshavarzian A., Young M., Wade M., Bocckino S., Day B.J., Banan A. Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats. Digestive Diseases and Sciences. 46:2001;2222-2230
14. + T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease. Journal of Experimental Medicine. 187:1998;855-864
15. D'Haens G., Van Deventer S., Van Hogezand R., Chalmers D., Kothe C., Baert F., Braakman T., Schaible T.F., Geboes K., Rutgeerts P. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. Gastroenterology. 116:1999;1029-1034
16. Eaden J., Abrams A., Ekbom A., Jackson E., Mayberry J. Colorectal cancer prevention in ulcerative colitis: A case control study. Alimentary Pharmacology and Therapeutics. 14:2000;145-153
17. El-Haj T., Poole S., Farthing M.J.G., Ballinger A.B. Anorexia in a rat model of colitis: Interaction of interleukin-1 and hypothalamic serotonin. Brain Research. 927:2002;1-7
18. Eliakim R., Karmeli F., Cohen P., Rachmilewitz D., Shao J.S., Alpers D.H. Sulphydryl blocker-induced rat colitis is ameliorated by intravenous injection of antibody to colonic surfactant-like particle. Inflammatory Bowel Diseases. 5:1999;16-23
19. Elson C.O., Sartor R.B., Tennyson G.S., Riddell H. Experimental models of inflammatory bowel disease. Gastroenterology. 109:1995;1344-1367
20. Gratz R., Becker S., Sokolowski N., Schumann M., Bass D., Malnick S.D. Murine monoclonal anti-TNF antibody administration has a beneficial effect on inflammatory bowel disease that develops in IL-10 knockout mice. Digestive Diseases and Sciences. 47:2002;1723-1727
21. Hartmann G., Bidlingmaier C., Siegmund B., Albrich S., Schulze J., Tschoep K., Eigler A., Lehr H.A., Endres S. Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice. The Journal of Pharmacology and Experimental Therapeutics. 292:2000;22-30
22. Hibi T., Ogata H., Sakuraba A. Animal models of inflammatory bowel disease. Journal of Gastroenterology. 37:2002;409-417
23. Higgins L.M., Frankel G., Douce G., Dougan G., MacDonald T.T. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infection and Immunity. 67:1999;3031-3039
24. Ilan Y., Weksler-Zangen S., Ben-Horin S., Diment J., Sauter B., Rahbani E., Engelhardt D., Roy Chowdhury N., Roy Chowdhury J., Goldin E. Treatment of experimental colitis by oral tolerance induction: A central role for suppressor lymphocytes. American Journal of Gastroenterology. 95:2000;966-973
25. Jijon H.B., Churchill T., Malfair D., Wessler A., Jewell L.D., Parsons H.G., Madsen K.L. Inhibition of poly (ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. American Journal of Physiology. Gastrointestinal and Liver Physiology. 279:2000;G641-G651
26. Kankuri E., Vaali K., Korpela R., Paakkari I., Vapaatalo H., Moilanen E. Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. Inflammation. 25:2001;301-310
27. Kato S., Hokari R., Matsuzaki K., Iwai A., Kawaguchi A., Nagao S., Miyahara T., Itoh K., Ishii H., Miura S. Amelioration of murine experimental colitis by inhibition of mucosal addressing cell adhesion molecule-1. The Journal of Pharmacology and Experimental Therapeutics. 295:2000;183-189
28. Kontoyiannis D., Pasparakis M., Pizarro T., Cominelli F., Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies. Immunity. 10:1999;387-398
29. Krieglstein C.F., Anthoni C., Rijcken E.J.M., Laukötter M., Spiegel H.U., Boden S.E., Schweizer S., Safayhi H., Senninger N., Schürmann G. Acetyl-11-keto-β-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis. International Journal of Colorectal Diseases. 16:2001;88-95
30. Krieglstein C.F., Cerwinka W.H., Stephen Laroux F., Salter J.W., Russel J.M., Schuermann G., Grisham M.B., Ross C.R., Neil Granger D. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: Divergent roles of superoxide and nitric oxide. Journal of Experimental Medicine. 194:2001;1207-1218
31. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:1993;263-274
32. Kuralay F., Yildiz C., Ozutemiz O., Islekel H., Caliskan S., Bingol B., Ozkal S. Effects of trimetazidine on acetic acid-induced colitis in female Swiss rats. Journal of Toxicology and Environmental Health. Part A. 66:2003;169-179
33. Levine A., Gabriel K., Bruck R., Avni Y., Abinoach I., Aeed H., Matas Z., David M., Yayon A. Effect of heparin on tissue binding activity of fibroblast growth factor and heparin-binding epidermal growth factor in experimental colitis in rats. Pediatric Research. 51:2002;635-640
34. Lindsay J.O., Ciesielski C.J., Scheinin T., Brennan F.M., Hodgson H.J. Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis. Gut. 52:2003;981-987
35. Loher F., Schmall K., Freytag P., Landauer N., Hallwachs R., Bauer C., Siegmund B., Rieder F., Lehr H.A., Dauer M., Kapp J.F., Endres S., Eigler A. The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice. The Journal of Pharmacology and Experimental Therapeutics. 305:2003;549-556
36. MacPherson B.R., Pfeiffer C.J. Experimental production of diffuse colitis in rats. Digestion. 17:1978;135-150
37. Mane J., Fernandez-Banare F., Ojanguren I., Castella E., Bertran X., Bartoli R., Alvarez M., Gassul M.A. Effect of L-arginine on the course of experimental colitis. Clinical Nutrition. 20:2001;415-422
38. Marini M., Bamias G., Riviera-Nieves J., Moskaluk C., Hoang S.B., Ross W.G., Pizarro T.T., Cominelli F. TNF-α neutralization ameliorated the severity of murine Crohn's-like ileitis by abrogation of intestinal cell apoptosis. PNAS. 100:2003;8366-8371
39. Marrero J.A., Matkowskyj K.A., Yung K., Hecht G., Benya R.V. Dextran sulfate sodium-induced murine colitis activates NF-κB and increases galanin-1 receptor expression. American Journal of Physiology. Gastrointestinal and Liver Physiology. 278:2000;G797-G804
40. Mashimo H., Wu D., Podolsky D., Fishman M. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 274:1996;262-265
41. Matsumoto S., Okabe Y., Setoyama H., Takayama K., Ohtsuka J., Funahashi H., Imaoka A., Okada Y., Umesaki Y. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut. 43:1998;71-78
42. McCartney S., Ballinger A.B., Vojnovic I., Farthing M.J.G., Warner T.D. Endothelin in human inflammatory bowel disease: Comparison to rat trinitrobenzenesulphonic acid-induced colitis. Life Sciences. 71:2002;1893-1904
43. Mombaerts P., Mizoguchi E., Grusby M., Glimcher L., Bhan A., Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 75:1993;274-282
44. + T cells. Journal of Experimental Medicine. 178:1993;237-244
45. Murano M., Maemura K., Hirata I., Toshina K., Nishikawa T., Hamamoto N., Sasaki S., Saitoh O., Katsu K. Therapeutic effect of intracolonically administered nuclear factor κB (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clinical and Experimental Immunology. 120:2000;51-58
46. Neurath M., Fuss I., Kelsall B., Stuber E., Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. Journal of Experimental Medicine. 182:1995;1281-1290
47. Neurath M.F., Pettersson S., Meyer zum Buschenfelde K.H., Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa Babrogates established experimental colitis in mice. Nature Medicine. 2:1996;998-1004
48. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 98:1990;694-702
49. Rath H., Ikeda J., Linde H., Scholmerich J., Wilson K., Sartor R. Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology. 116:1999;310-319
50. Rath H.C. Role of commensal bacteria in chronic experimental colitis: Lessons form the HLA-B27 transgenic rat. Pathobiology. 70:2003;131-138
51. Rath H.C., Schultz M., Freitag R., Dieleman L.A., Li F., Linde H.J., Scholmerich J., Sartor R.B. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immunology. 69:2001;2277-2285
52. -/-) mice and intestinal inflammation. American Journal of Physiology. Gastrointestinal and Liver Physiology. 278:2000;G829-G833
53. Riviera-Nieves J., Bamias G., Vidrich A., Marini M., Pizarro T.T., McDuffie M.J., Moskaluk C.A., Cohn S.M., Cominelli F. Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis. Gastroenterology. 124:2003;972-982
54. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:1993;253-261
55. Sartor R., Bond T., Schwab J. Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury. Infection and Immunity. 56:1988;2101-2108
56. Satoh H., Sato F., Takami K., Szabo S. New ulcerative colitis model induced by sulfhydryl blockers in rats and the effects of antiinflammatory drugs on the colitis. Japanese Journal of Pharmacology. 73:1997;299-309
57. Seril D.N., Liao J., Ho K.L., Warsi A., Yang C.S., Yang G.Y. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Digestive Diseases and Sciences. 47:2002;1266-1278
58. Seril D.N., Liao J., Ho K.L., Yang C.S., Yang G.Y. Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma in a murine model by N-acetylcysteine. Carcinogenesis. 23:2002;993-1001
59. + T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG in their action. General Pharmacology. 31:1998;477-481
60. Sohn K.J., Shah S.A., Reid S., Choi M., Carrier J., Comiskey M., Terhorst C., Kim Y.I. Molecular genetics of ulcerative colitis-associated colon cancer in the interleukin 2- and β2-microglobulin-deficient mouse. Cancer Research. 61:2001;6912-6917
61. Soriano A., Salas A., Miquel S., Gironella M., Elena M., Anderson D.C., Piqué J.M., Panés J. VCAM-1, but not ICAM-1 or MAdCAM-1 immunoblockade ameliorated DSS-induced colitis in mice. Laboratory Investigation. 80:2000;1541-1551
62. Stein J., Ries J., Barret K. Disruption of intestinal barrier function associated with experimental colitis: Possible role of mast cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 274:1998;G203-G209
63. Steinhoff U., Brinkmann V., Klemm U., Aichele P., Seiler P., Brandt U., Bland P.W., Prinz I., Zugel U., Kaufmann S.H. Autoimmune intestinal pathology induced by hsp60-specific CD8 T cells. Immunity. 11:1999;349-358
64. Takahashi I., Kiyono H., Hamada S. CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology. 112:1997;1876-1886
65. Targan S.R., Hanauer S.B., van Deventer S.J., Mayer L., Present D.H., Braakman T., DeWoody K.L., Schaible T.F., Rutgeerts P.J. A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's disease cA2 study group. New England Journal of Medicine. 337:1997;1029-1035
66. Varilek G.W., Yang F., Lee E.Y., deVilliers W.J.S., Zhong J., Oz H.S., Westverry K.F., McClain C. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. Journal of Nutrition. 131:2001;2034-2039
67. Watanabe M., Watanabe N., Iwao Y., Ogata H., Kanai T., Ueno Y., Tsuchiya M., Ishii H., Aiso S., Habu S., Hibi T. The serum factor from patients with ulcerative colitis that induces T cell proliferation in the mouse thymus is interleukin-7. Journal of Clinical Immunology. 17:1997;282-292
68. Watanabe M., Yamazaki M., Kanai T. Mucosal T cells as a target for treatment of IBD. Journal of Gastroenterology. 38(Suppl. 15):2003;48-50
69. Watanabe N., Ikuta K., Okazaki K., Nakase H., Tabata Y., Matsuura M., Tamaki H., Kawanami C., Honjo T., Chiba T. Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice. Digestive Diseases and Sciences. 48:2003;408-414
70. Wirtz S., Becker C., Blumberg R., Galle P.R., Neurath M.F. Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA. Journal of Immunology. 168:2002;411-420
71. Wirtz S., Finotto S., Kanzler S., Lohse A., Blessing M., Lehr H., Galle P., Neurath M. Cutting edge: Chronic intestinal inflammation in STAT-4 transgenic mice: Characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens. Journal of Immunology. 162:1999;1884-1888
72. Yamada T., Marshall S., Specian R.D., Grisham M.B. A comparative analysis of two models of colitis in rats. Gastroenterology. 102:1991;1524-1534